Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia (Q46887850)
Jump to navigation
Jump to search
scientific article published in November 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia |
scientific article published in November 2007 |
Statements
1 reference
Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia (English)
1 reference
T De Marinis
1 reference
P T Saleem
1 reference
P Glue
1 reference
W J Arnoldussen
1 reference
R Teijeiro
1 reference
A Lex
1 reference
M A Latif
1 reference
R Medori
1 reference
1 November 2007
1 reference
1 reference
40
1 reference
6
1 reference
257-263
1 reference
Identifiers
1 reference